Patent · US Active

Process for the preparation of novel pyridopyrazines as mTOR kinase inhibitors

US8198441B2 · kind B2 · utility

0Cited by
2References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 18, 2009
Grant dateJun 12, 2012
Priority date
Expiry dateFeb 9, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided a process for the preparation of a compound of Formula 1,the use of said process in the preparation of a compound of Formula 5or a phosphate, sulphate, hydrogensulphate, malate, citrate, tartrate or fumarate salt thereof, and the use of the fumarate salt in a composition for use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.